Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2280
+0.0073 (3.31%)
At close: Aug 13, 2025, 4:00 PM
0.2224
-0.0056 (-2.46%)
Pre-market: Aug 14, 2025, 9:22 AM EDT
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 10 employees as of December 31, 2024. The number of employees decreased by 3 or -23.08% compared to the previous year.
Employees
10
Change (1Y)
-3
Growth (1Y)
-23.08%
Revenue / Employee
n/a
Profits / Employee
-$1,288,173
Market Cap
11.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PCSA News
- 7 days ago - Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies - GlobeNewsWire
- 6 weeks ago - Processa Pharmaceuticals Provides Portfolio and Business Update - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025 - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting - GlobeNewsWire
- 4 months ago - Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - GlobeNewsWire